We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
+17.5%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$11.5B
AUM Growth
+$1.63B
Cap. Flow
+$51.4M
Cap. Flow %
0.45%
Top 10 Hldgs %
18.23%
Holding
122
New
3
Increased
87
Reduced
28
Closed
2

Top Sells

Rank Stock Value
1
OKTA icon
Okta
OKTA
+$109M
2
RHT
Red Hat Inc
RHT
+$97.8M
3
WDAY icon
Workday
WDAY
+$55.9M
4
WWD icon
Woodward
WWD
+$55.1M
5
RBA icon
RB Global
RBA
+$39.5M

Sector Composition

Rank Sector Weight
1 Healthcare 22.7%
2 Technology 20.18%
3 Industrials 15.65%
4 Financials 12.87%
5 Consumer Staples 12.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AME icon
26
Ametek
AME
$53.9B
$144M 1.26%
1,736,825
+140,290
+9% +$10.7M
XRAY icon
27
Dentsply Sirona
XRAY
$2.85B
$143M 1.25%
2,890,795
+80,555
+3% +$3.55M
TECH icon
28
Bio-Techne
TECH
$11.2B
$143M 1.25%
2,880,360
+47,960
+2% +$2.16M
PB icon
29
Prosperity Bancshares
PB
$8.9B
$140M 1.22%
2,032,300
+47,085
+2% +$3.36M
EW icon
30
Edwards Lifesciences
EW
$49.4B
$139M 1.21%
2,183,700
+172,170
+9% +$9.83M
FLO icon
31
Flowers Foods
FLO
$1.58B
$134M 1.17%
6,293,150
+110,665
+2% +$2.22M
NTNX icon
32
Nutanix
NTNX
$16.1B
$133M 1.16%
3,515,550
+1,110,780
+46% +$50.8M
ROK icon
33
Rockwell Automation
ROK
$51.1B
$132M 1.15%
752,680
+27,115
+4% +$4.61M
IEX icon
34
IDEX
IEX
$17B
$132M 1.15%
866,810
+85,845
+11% +$12.1M
NUVA
35
DELISTED
NuVasive, Inc.
NUVA
$129M 1.13%
2,275,140
-264,990
-10% -$14.1M
OKTA icon
36
Okta
OKTA
$23.8B
$123M 1.07%
1,489,130
-1,379,940
-48% -$109M
SXT icon
37
Sensient Technologies
SXT
$5.22B
$123M 1.07%
1,812,105
+8,920
+0.5% +$562K
LOGM
38
DELISTED
LogMein, Inc.
LOGM
$122M 1.06%
1,519,600
+33,365
+2% +$2.85M
CNMD icon
39
CONMED
CNMD
$1.3B
$119M 1.04%
1,433,335
+11,155
+0.8% +$810K
AAP icon
40
Advance Auto Parts
AAP
$3.52B
$118M 1.03%
693,505
+46,875
+7% +$7.57M
HRL icon
41
Hormel Foods
HRL
$14.2B
$116M 1.01%
2,585,655
-65,015
-2% -$2.78M
COO icon
42
Cooper Companies
COO
$14.3B
$116M 1.01%
1,562,880
+4,840
+0.3% +$338K
CMD
43
DELISTED
Cantel Medical Corporation
CMD
$113M 0.98%
1,688,315
+822,495
+95% +$62.3M
IFF icon
44
International Flavors & Fragrances
IFF
$20.3B
$112M 0.98%
868,390
+27,455
+3% +$3.64M
ARGO
45
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$112M 0.97%
1,580,413
+27,850
+2% +$1.89M
LH icon
46
Labcorp
LH
$25.2B
$111M 0.97%
848,236
+25,346
+3% +$3.12M
MASI
47
DELISTED
Masimo
MASI
$110M 0.96%
795,720
-2,930
-0.4% -$368K
BF.B icon
48
Brown-Forman Class B
BF.B
$13.5B
$109M 0.95%
2,073,430
+637,265
+44% +$30.9M
TAP icon
49
Molson Coors Class B
TAP
$8.02B
$109M 0.95%
1,829,265
+59,780
+3% +$3.69M
WBT
50
DELISTED
Welbilt, Inc.
WBT
$104M 0.91%
6,345,165
+177,290
+3% +$2.59M

Similar funds

Champlain Investment Partners's Q1 2019 Portfolio in Review

As of Q1 2019, Champlain Investment Partners held 122 positions worth $11.5B, up 17% from $9.84B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 4.1%. Champlain Investment Partners opened 3 new positions and exited 2, leaving the 122-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.

  • Champlain Investment Partners's largest Q1 2019 buy was Freshpet: 496,940 shares worth $21M.
  • Champlain Investment Partners added most to Cantel Medical Corporation in Q1 2019, an estimated $62.3M increase.
  • Champlain Investment Partners's biggest Q1 2019 reduction was Okta, cutting an estimated $109M.
  • Champlain Investment Partners fully exited El Pollo Loco in Q1 2019, selling an estimated $12.8M.
  • Champlain Investment Partners's ten largest holdings make up 18% of its $11.5B portfolio in Q1 2019.
  • Champlain Investment Partners opened 3 new positions and closed 2 in Q1 2019.
  • Champlain Investment Partners's portfolio value rose 17% quarter-over-quarter to $11.5B.

Based on Champlain Investment Partners's 13F filing for Q1 2019, filed 14 May 2019.